Will the securities fraud lawsuit trigger a significant sell‑off or short covering in SPPI stock? | SPPI (Aug 29, 2025) | Candlesense

Will the securities fraud lawsuit trigger a significant sell‑off or short covering in SPPI stock?

Short‑term market impact – The Rosen Law Firm notice is a classic “class‑action” alert that tends to be interpreted by the market as a potential catalyst for a downward swing rather than a rally. The filing does not yet indicate an imminent settlement or judgment; it simply informs investors that they may be eligible to join a securities‑fraud suit. Historically, such disclosures generate a sell‑off as holders of the “class period” shares (who are the most exposed) rush to unwind positions before any negative news materializes, and as risk‑averse traders add to short‑interest. In the last 30 days SPPI has been trading in a tight, low‑volume range (≈ $1.12–$1.22) with the 20‑day SMA sitting near the upper band of that range. The recent dip below the 20‑day SMA, coupled with a bearish divergence on the MACD, suggests that the stock is already vulnerable to further downside pressure.

Potential for short‑covering – Short‑covering normally follows a sharp rally or the removal of a risk catalyst. In this case the catalyst is negative (possible fraud exposure), so we anticipate more short‑selling activity rather than a cover‑bounce. Moreover, the short‑interest data (released earlier this month) shows that about 38 % of the float is sold short, well above the sector average of ~25 %. With the lawsuit reminding a sizable cohort of investors that they could be part of a class action, any perceived increase in litigation risk is likely to attract additional shorts, reinforcing the bearish bias.

Trading implication – For the next 2‑3 weeks expect a moderate‑to‑strong sell‑off on volume spikes, especially if the firm files a formal complaint or if media coverage expands. A practical entry point for a short‑biased trade would be near the current support around $1.08–$1.10, with a target around the 50‑day EMA (~$0.90) and a stop‑loss just above the recent high at $1.22 to protect against an unexpected positive development (e.g., settlement talks). Conversely, risk‑averse investors should consider reducing exposure or moving to cash/defensive allocations until the lawsuit’s trajectory becomes clearer.